search Created with Sketch.
search Created with Sketch.

Advertisement

dermwire-tv-logo Created with Sketch.
dermwire-tv-logo Created with Sketch.

Skin Cancer Awareness, Epiduo Data, Impoyz Launch

Data shed light on patents' attitudes towards kids' sunblock and new findings emerge on melanoma risks. FDA accepts BLA for cemiplimab for advanced SCC and approves Novartis' Tafinlar in combination with Mekinist for the adjuvant treatment of patients with melanoma with BRAF V600E or V600K mutations. Data highlight clinical experience with Epiduo Forte Gel. Encore Dermatology launches Impoyz Cream.

Advertisement

In This Series

View More

Advertisement